Role of the Computational Intelligence in Drugs Discovery and Design: Introduction, Techniques and Software

Drugs discovery & design is an intense, lengthy and consecutive process that starts with the lead & target discovery followed by lead optimization and pre-clinical in vitro & in vivo studies. This paper throws light on different computational techniques that play a vital role in the drugs discovery & design process. Earlier, computational techniques are use in the field of computer science, electrical engineering and electronics & communication engineering to solve the problems. But, now day’s use of these techniques has changed the scenario in drugs discovery. & design from the last two decades. This paper present brief description of different computational techniques such as Particle Swarm Optimization, Ant Colony Optimization, Artificial Neural Network, Fuzzy logic, Genetic Algorithm, Genetic Programming, Evolutionary Programming, Evolutionary Strategy and also provide a tabular comparison of these techniques as well as a list of computational tools/ software.

[1]  Chrysostomos D. Stylios,et al.  An integrated two-level hierarchical system for decision making in radiation therapy based on fuzzy cognitive maps , 2003, IEEE Transactions on Biomedical Engineering.

[2]  W S McCulloch,et al.  A logical calculus of the ideas immanent in nervous activity , 1990, The Philosophy of Artificial Intelligence.

[3]  John R. Koza,et al.  Genetic programming: a paradigm for genetically breeding populations of computer programs to solve problems , 1990 .

[4]  Kimito Funatsu,et al.  GA Strategy for Variable Selection in QSAR Studies: GA-Based Region Selection for CoMFA Modeling , 1998, J. Chem. Inf. Comput. Sci..

[5]  Thomas Bäck,et al.  Evolutionary computation: Toward a new philosophy of machine intelligence , 1997, Complex..

[6]  Wei Kong,et al.  A combination of modified particle swarm optimization algorithm and support vector machine for gene selection and tumor classification. , 2007, Talanta.

[7]  Lawrence J. Fogel,et al.  Artificial Intelligence through Simulated Evolution , 1966 .

[8]  Jelena Parojčić,et al.  Artificial intelligence in pharmaceutical product formulation: Neural computing , 2009 .

[9]  Riccardo Poli,et al.  Particle swarm optimization , 1995, Swarm Intelligence.

[10]  H. Maarten Vinkers,et al.  An ant algorithm for the conformational analysis of flexible molecules , 2007, J. Comput. Chem..

[11]  Vidroha Debroy,et al.  Genetic Programming , 1998, Lecture Notes in Computer Science.

[12]  Aboul Ella Hassanien,et al.  Intelligent data analysis of breast cancer based on rough set theory , 2003, Int. J. Artif. Intell. Tools.

[13]  Gennady M Verkhivker,et al.  Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. , 1995, Chemistry & biology.

[14]  Ajith Abraham,et al.  Swarm Intelligence in Data Mining , 2009, Swarm Intelligence in Data Mining.

[15]  M. Jamshidi,et al.  Determining flexor-tendon repair techniques via soft computing , 2001, IEEE Engineering in Medicine and Biology Magazine.

[16]  Kimito Funatsu,et al.  GA Strategy for Variable Selection in QSAR Studies: Application of GA-Based Region Selection to a 3D-QSAR Study of Acetylcholinesterase Inhibitors , 1999, J. Chem. Inf. Comput. Sci..

[17]  K. Thurow,et al.  Robust fuzzy mappings for QSAR studies. , 2007, European journal of medicinal chemistry.

[18]  Thomas Bäck,et al.  A Survey of Evolution Strategies , 1991, ICGA.

[19]  Vigneshwaran Namasivayam,et al.  Research Article: pso@autodock: A Fast Flexible Molecular Docking Program Based on Swarm Intelligence , 2007, Chemical biology & drug design.

[20]  Ingo Rechenberg,et al.  Evolutionsstrategie : Optimierung technischer Systeme nach Prinzipien der biologischen Evolution , 1973 .

[21]  Beth A Sproule,et al.  Fuzzy pharmacology: theory and applications. , 2002, Trends in pharmacological sciences.

[22]  Marco Furini,et al.  International Journal of Computer and Applications , 2010 .

[23]  Zhiwei Wang,et al.  Particle swarm optimization and neural network application for QSAR , 2004, 18th International Parallel and Distributed Processing Symposium, 2004. Proceedings..

[24]  Johann Gasteiger,et al.  Neural networks and genetic algorithms in drug design , 2001 .

[25]  Juan J. Nieto,et al.  Fuzzy Logic in Medicine and Bioinformatics , 2006, Journal of biomedicine & biotechnology.

[26]  Mehdi Jalali-Heravi,et al.  Use of Artificial Neural Networks in a QSAR Study of Anti-HIV Activity for a Large Group of HEPT Derivatives , 2000, J. Chem. Inf. Comput. Sci..

[27]  Frank Rosenblatt,et al.  PRINCIPLES OF NEURODYNAMICS. PERCEPTRONS AND THE THEORY OF BRAIN MECHANISMS , 1963 .

[28]  Raouf N. Gorgui-Naguib,et al.  A fuzzy logic based-method for prognostic decision making in breast and prostate cancers , 2003, IEEE Transactions on Information Technology in Biomedicine.

[29]  Jyrki Taskinen,et al.  Aqueous Solubility Prediction of Drugs Based on Molecular Topology and Neural Network Modeling , 1998, J. Chem. Inf. Comput. Sci..

[30]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[31]  G Schneider,et al.  Artificial neural networks for computer-based molecular design. , 1998, Progress in biophysics and molecular biology.

[32]  Dmitry Yu. Zubarev,et al.  Global minimum structure searches via particle swarm optimization , 2007, J. Comput. Chem..

[33]  F. Burden,et al.  Robust QSAR models using Bayesian regularized neural networks. , 1999, Journal of medicinal chemistry.

[34]  J L Katz,et al.  2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors. , 2000, Journal of medicinal chemistry.

[35]  David B. Fogel,et al.  Evolutionary Computation: Towards a New Philosophy of Machine Intelligence , 1995 .

[36]  Gisbert Schneider,et al.  Artificial neural networks and simulated molecular evolution are potential tools for sequence-oriented protein design , 1994, Comput. Appl. Biosci..

[37]  Saman K. Halgamuge,et al.  Particle Swarm Optimisation for Protein Motif Discovery , 2004, Genetic Programming and Evolvable Machines.

[38]  I. Couzin,et al.  Collective memory and spatial sorting in animal groups. , 2002, Journal of theoretical biology.

[39]  Moshe Sipper,et al.  Evolutionary computation in medicine: an overview , 2000, Artif. Intell. Medicine.

[40]  T Lavé,et al.  Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. , 1999, Journal of medicinal chemistry.

[41]  D. Agrafiotis,et al.  Feature selection for structure-activity correlation using binary particle swarms. , 2002, Journal of medicinal chemistry.

[42]  Amit Konar,et al.  Swarm Intelligence Algorithms in Bioinformatics , 2008, Computational Intelligence in Bioinformatics.

[43]  W. L. Jorgensen.  The Many Roles of Computation in Drug Discovery , 2004, Science.

[44]  Frank R. Burden,et al.  Use of Automatic Relevance Determination in QSAR Studies Using Bayesian Neural Networks , 2000, J. Chem. Inf. Comput. Sci..

[45]  K. Nakakimura,et al.  Hypertension control during anesthesia. Fuzzy logic regulation of nicardipine infusion , 1994, IEEE Engineering in Medicine and Biology Magazine.

[46]  Peter Willett,et al.  Evaluation of the EVA descriptor for QSAR studies: 3. The use of a genetic algorithm to search for models with enhanced predictive properties (EVA_GA) , 2000, J. Comput. Aided Mol. Des..

[47]  Lotfi A. Zadeh,et al.  Outline of a New Approach to the Analysis of Complex Systems and Decision Processes , 1973, IEEE Trans. Syst. Man Cybern..